Reference health
Molecular Evolutionary Process of Advanced Gastric Cancer During Sequential Chemotherapy Detected by Circulating Tumor DNA
34/34 checkable references clean · checked 2026-07-24
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
20 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 34 checked references that resolve
resolves10.1200/JCO.2009.25.4706
Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
resolves10.1200/JCO.2012.48.5805
Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial
resolves10.1158/2159-8290.CD-19-0487
Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma
resolves10.1038/s41591-018-0101-z
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
resolves10.2147/CMAR.S172710
Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis
resolves10.1016/j.ccell.2020.03.012
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
resolves10.1093/bioinformatics/btp324
Fast and accurate short read alignment with Burrows–Wheeler transform
resolves10.1093/nar/gkq603
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
resolves10.1371/journal.pcbi.1004873
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
resolves10.1038/s41588-020-0590-9
Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer
resolves10.1093/bioinformatics/btw313
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
resolves10.1007/s00280-019-03982-4
Dose-finding study of modified FLOT (mFLOT) regimen as first-line treatment in Chinese patients with metastatic adenocarcinoma of stomach
resolves10.1016/j.cell.2018.04.012
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
resolves10.1038/nm.3850
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
resolves10.1186/s12881-019-0909-5
Copy number variation is highly correlated with differential gene expression: a pan-cancer study
resolves10.1016/j.cell.2017.01.018
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
resolves10.1182/blood.2019002220
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
resolves10.1182/blood-2009-10-248526
CYLD regulates angiogenesis by mediating vascular endothelial cell migration
resolves10.1016/j.bbrc.2021.04.028
The circACC1/miR-29c-3p/FOXP1 network plays a key role in gastric cancer by regulating cell proliferation
resolves10.1001/jamaoncol.2018.0013
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
resolves10.1158/2159-8290.CD-14-0462
Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
resolves10.1158/2159-8290.CD-19-0442
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial
resolves10.1038/s41573-019-0044-1
The great escape: tumour cell plasticity in resistance to targeted therapy
resolves10.1200/JCO.19.03296
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
The 20 references without a DOI — listed, not checked
no DOI — not checkedCancer statistics in China
no DOI — not checkedNational trend of gastric cancer mortality in China
no DOI — not checkedCurrent treatment and recent progress in gastric cancer
no DOI — not checkedClinical and genomic landscape of gastric cancer with a mesenchymal phenotype
no DOI — not checkedComprehensive pharmacogenomic characterization of gastric cancer
no DOI — not checkedref11
no DOI — not checkedref17
no DOI — not checkedFrom FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline
no DOI — not checkedref31
no DOI — not checkedref33
no DOI — not checkedMulti-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
no DOI — not checkedWind NS, Holen I. Multidrug resistance in breast cancer: from in vitro models to clinical studies
no DOI — not checkedref40
no DOI — not checkedref42
no DOI — not checkedref43
no DOI — not checkedref45
no DOI — not checkedHighlights in Resistance Mechanism Pathways for Combination Therapy
no DOI — not checkedref48
no DOI — not checkedref51
no DOI — not checkedref53
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.3929959"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3929959/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.3929959)